Navigation Links
University of Rochester named Center for AIDS Research by the National Institutes of Health
Date:5/9/2013

re than 20 years and this gives us the opportunity to reach out more broadly across the institution than ever before in search of new ideas, talent and inspiration."

The CFAR will include two major working groups. The first, led by Harris "Handy" A. Gelbard, M.D., Ph.D., director of the Center for Neural Development and Disease and an international expert on HIV-associated dementia, will focus on the virus' affect on the brain and what it means for aging patients.

Thanks to great strides in treatment, people with HIV are living longer than ever before: More than 45 percent of patients who receive care at URMC's AIDS Center are 50 years of age or older and more than 15 percent are 60 or older. According to Gelbard, this is a new phenomenon, and little is known about how HIV interacts with other conditions associated with aging, such as age-related cognitive decline. Gelbard says the group will take advantage of the Medical Center's expertise in neurology clinical trials and novel imaging tools and techniques developed by the Institute of Optics to investigate AIDS and the aging brain.

David H. Mathews, M.D., Ph.D., associate professor in the Department of Biochemistry and Biophysics, will head the second working group focused on HIV RNA biology. The genetic material of HIV (its genome) is composed of RNA or ribonucleic acid, which is used to make DNA that then inserts itself in the chromosome of the host cell. Better understanding the structure and function of HIV RNA and how it replicates will give researchers the opportunity to target different aspects of the virus that haven't been targeted in the past. Such information could be used to develop new drug treatments and to facilitate the eradication of latent reservoirs of virus infection.

"We have a concentration of the world's leading RNA investigators here at the University," said Mathews, associate director of URMC's Center for RNA Biology. "Our goal is to encourage RNA
'/>"/>

Contact: Emily Boynton
emily_boynton@urmc.rochester.edu
585-273-1757
University of Rochester Medical Center
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. University of Cincinnati researchers win $3.7M grant from US Department of Defense
2. Leading experts on congenital muscular dystrophy convene at University of Nevada, Reno
3. Rice University student engineers automate limb lengthening for kids
4. Louisiana Tech University professor earns NSF Early Career Development grant
5. Neuropsychologist receives University of Houstons highest faculty honor
6. University of Houston Graduate College of Social Work announces partnership with MD Anderson
7. Columbia University Medical Center and NY-Presbyterian experts at APA meeting
8. University of Minnesota startup to treat challenging bacterial infection
9. University studies and career expectations of medical students
10. McMaster University researchers discover drug destroys human cancer stem cells but not healthy ones
11. Feola, at University of Kentucky, receives NIH grant to study cystic fibrosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... PA (PRWEB) July 29, 2014 ... the Sewickley and Moon Township areas, has affiliated with ... Women’s Health will continue to deliver babies and perform ... need of advanced care will be referred to Allegheny ... are proud to be associated with West Penn Hospital ...
(Date:7/29/2014)... 2014 Representatives with BNatrl announced today ... BNatrl Silver Solution 12ppm . , “It’s safe ... for BNatrl LLC. “It helps boost your immune system ... pathogens and microbes.” , BNatrl develops and manufactures organic ... with 10 percent of profits being used to fund ...
(Date:7/29/2014)... 2014 Regents Health Resources, a consulting ... brought health care industry veteran Daryl Demonbreun and former ... lead the company’s ambitious plans to grow into a ... been moving along at a steady pace for nearly ... a notch,” says Bob Maier, founder and chief executive ...
(Date:7/29/2014)... According to the new market research report, "Fingerprint ... (Optical Prism, Pizeoelectric, Capacitive, and Adhesives), Application (Mobile ... & Finance), and Geography - Global Trends & ... the global Fingerprint Sensors Market is projected to ... high CAGR of 16.8% from 2014 to 2020. ...
(Date:7/29/2014)... 2014 This Latest Guidebook for Conducting ... (2014 Edition) not only provided a comprehensive and thorough ... for imported drug registration but also introduced the practical ... guide you to use the Chinese trial venues to ... world step by step. , The audiences of this ...
Breaking Medicine News(10 mins):Health News:Leading West Suburban OBGYN Practice, Premier Women’s Health, Joins Allegheny Health Network 2Health News:Leading West Suburban OBGYN Practice, Premier Women’s Health, Joins Allegheny Health Network 3Health News:BNatrl Launches New Silver Solution Product 2Health News:Sferrella and Demonbruen Join Regents Health Resources 2Health News:Fingerprint Sensors Market by Type (Swipe And Area) Estimated to Reach $14.35 Billion by 2020 - New Report by MarketsandMarkets 2Health News:Fingerprint Sensors Market by Type (Swipe And Area) Estimated to Reach $14.35 Billion by 2020 - New Report by MarketsandMarkets 3Health News:Fingerprint Sensors Market by Type (Swipe And Area) Estimated to Reach $14.35 Billion by 2020 - New Report by MarketsandMarkets 4Health News:Pharma Clinical Trials Market in China: Authorities for Drug New Study Now Available at MarketReportsOnline.com 2Health News:Pharma Clinical Trials Market in China: Authorities for Drug New Study Now Available at MarketReportsOnline.com 3Health News:Pharma Clinical Trials Market in China: Authorities for Drug New Study Now Available at MarketReportsOnline.com 4
... Va. Research reported in the October issue of ... a molecular imaging technique may prove useful in early ... "One of the most promising aspects of molecular ... long before changes in the tumor size and shape ...
... review article published in the October issue of ... Clinic physicians differentiate the ethical and legal permissibility ... comfort measures, specifically palliative sedation, from that of ... that palliative sedation has an important place on ...
... published study in the October 2010 issue of The ... conducted at New York University,s College of Dentistry, confirms ... for controlling xerostomia, or dry mouth. The double masked, ... unique mucoadhesive patch, affixed to the hard palate inside ...
... It Real," an evidence-based sex education curriculum developed by researchers ... (UTHealth), will be implemented in select public schools across the ... tackle the U.S. teenage pregnancy rate. The U.S. ... of its $155-million total package to a team led by ...
... sciences for the developing world, will hold its 21st General ... 350 scientists from 35 countries are expected to attend. Dr. ... delegates at the opening ceremony. The opening ceremony will ... Ernesto Illy Trieste Science Prize and the official presentation of ...
... is a major cause of vision problems in children and ... 70 in developed countries. In amblyopia the person,s stronger eye ... as a result. When the condition is detected and treated ... 20/30 vision or better, the Amblyopia Treatment Study reports. But ...
Cached Medicine News:Health News:Evaluation of targeted therapy in ovarian cancer 2Health News:New approach for treating dry mouth presented in study published in October 2010 issue of JADA 2Health News:New approach for treating dry mouth presented in study published in October 2010 issue of JADA 3Health News:UTHealth researchers awarded $15 million for teen pregnancy prevention 2Health News:TWAS to meet in India 2Health News:Is photoscreening the best way to catch 'lazy eye'? 2
(Date:7/29/2014)... DUBLIN , July 29, 2014 ... the "Global Respiratory Devices Market 2014-2018" report ... A respiratory device is a medical ... who is having difficulty in breathing and cannot achieve ... disorders such as cystic fibrosis, asthma, COPD, and ARDS ...
(Date:7/29/2014)...  The Healthcare Analytics Summit 2014 (HAS ... Salt Lake City , Sept. 24-25 has added ... organizations in the U.S. and beyond.  HAS ,14, powered ... devoted to providing immersive learning experiences on the ... accountable care initiatives and population health managemen t ...
(Date:7/29/2014)... July 29, 2014  Ambit Biosciences (Nasdaq: AMBI ... of drugs targeting unmet needs in oncology, autoimmune and ... operational results after closing of the NASDAQ Global Market ... conference call hosted by Michael Martino , president ... take place on the same day at 5:00 pm ...
Breaking Medicine Technology:Global Respiratory Devices Market 2014-2018 2Health Catalyst Adds Keynote Speakers, New Sessions, and Expands Attendee Limit for Healthcare Analytics Summit 2014 2Health Catalyst Adds Keynote Speakers, New Sessions, and Expands Attendee Limit for Healthcare Analytics Summit 2014 3Health Catalyst Adds Keynote Speakers, New Sessions, and Expands Attendee Limit for Healthcare Analytics Summit 2014 4Health Catalyst Adds Keynote Speakers, New Sessions, and Expands Attendee Limit for Healthcare Analytics Summit 2014 5Ambit Biosciences To Announce Second Quarter 2014 Financial Results 2
... NEW YORK , July 1 ... ("NeoStem" or the "Company"), an international,biopharmaceutical company with operations ... it has appointed Roberto Bolli , M.D., to ... body of stem-cell research,including work emphasizing the ability of ...
... July 1 Sagent Pharmaceuticals, Inc., a ... U.S. Food and Drug Administration (FDA) has approved the ... is a vital anticoagulant, preventing the formation of clots ... used in surgical and dialysis settings.  According to IMS, ...
Cached Medicine Technology:NeoStem Adds Distinguished Researcher to its World-Class Scientific Advisory Board 2NeoStem Adds Distinguished Researcher to its World-Class Scientific Advisory Board 3NeoStem Adds Distinguished Researcher to its World-Class Scientific Advisory Board 4FDA Approves Sagent Pharmaceuticals' Heparin Sodium Injection, USP 2FDA Approves Sagent Pharmaceuticals' Heparin Sodium Injection, USP 3FDA Approves Sagent Pharmaceuticals' Heparin Sodium Injection, USP 4
Angled 45 degree shafts with 10.5 mm tying and 1 mm of tip crisscross serrated. Serrated handle with dull finish. Manufactured in titanium. Overall length 3.2 inches....
Curved shafts with 4 mm tying platform. Serrated handle with dull finish. Manufactured in titanium. Overall length 3.3 inches....
Straight, 7 mm tying platform. Castroviejo handle. Manufactured in titanium. Overall length 4.2 inches....
Angled Castroviejo handle. Manufactured in titanium. Overall length 4.2 inches....
Medicine Products: